MPN News From ASH 2016: An Update From Dr. Claire Harrison


What is the latest in myeloproliferative neoplasms (MPNs) from the American Society of Hematology (ASH) annual meeting and what does it mean for patients?  Dr. Claire Harrison from Guy and St. Thomas’ Hospital reviews a consolidated list of MPN news which revolves around several studies:  PROUD-PV, MPD-RC 112 and the MPN Landmark Study, among others.  Dr. Harrison discloses interim results and summarizes the impact on MPN patients.  She also shares her predictions for the 2017 meeting including increased understanding of the genetic landscape for patients with MPNs.

Sign in or Register to view comments.